High Throughput Screening Market: Opportunities and Challenges

October 13 19:08 2019
High Throughput Screening Market: Opportunities and Challenges

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
The growth in this market is primarily attributed to the adoption of open innovative models in pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS and the availability of government funding and venture capital investments.

The global high-throughput screening market is expected to reach USD 21.69 billion by 2023 from USD 14.87 billion in 2017, at a CAGR of 7.8%. The growth in this market is primarily attributed to the adoption of open innovative models in pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS and the availability of government funding and venture capital investments. High-growth emerging markets and growing research activities in toxicology and stem cell research are expected to provide growth opportunities for players operating in the HTS market. However, capital-intensive nature of HTS and complexities in the field of assay development is expected to restrain the growth of this market to a certain extent.

What are the opportunities in emerging markets in the High Throughput Screening market?

Emerging countries such as India, China, and Brazil offer huge growth opportunities for market players with their diversified healthcare markets, low labor and raw materials costs, rising life science and research activities, government support, the rapid growth of CROs and the pharmaceutical industry, and technological integration and advancements. Governments of emerging countries have also spent significantly on encouraging research in the life sciences industry.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

For instance, the Department of Pharmaceuticals in India has prepared a “Pharma Vision 2020” document for making India a leading destination for drug discovery and innovation. Through this, the government provides support in terms of setting up world-class infrastructure, creating internationally competitive scientific manpower for pharma R&D, and supporting venture funding for public and private research. According to the World Bank, the R&D spending as a percentage of the GDP in China has increased from 1.71% in 2010 to 2.06% in 2015. In addition, according to the National Science Foundation (US), China overtook the EU in terms of spending on basic and applied research in science by spending USD 408.6 billion on R&D activities in 2015, which was slightly less than the US (USD 496.6 billion). In addition, according to OECD estimations, China is expected to overtake the US in terms of R&D spending by 2019.

The presence of a large patient and elderly population in emerging countries is a major factor driving the demand for research and diagnostic activities to produce new drugs. According to the International Diabetes Federation Atlas, in 2015, around 69.2 million people were suffering from diabetes in India; this figure was 63 million in 2013 (Source: WHO). Similarly, according to a survey conducted by the Chinese Center for Disease Control and Prevention, 11% of the Chinese population was suffering from diabetes in 2017. In addition, the geriatric population in Australia, as a percentage of the total population, has increased from 12.35% in 2000 to 15.25% in 2016.

Due to these factors, emerging markets such as India and China are expected to provide significant opportunities for the growth of the HTS market in the coming years.

What are the challenges with skilled operators in High Throughput Screening market?

HTS instruments such as flow cytometers, liquid handling systems, and multimode readers are relatively complex technologies and require expertise to be handled effectively.

However, there is a significant shortage of skilled personnel. A survey conducted by the Association of the British Pharmaceutical Industry (ABPI) in 2015 in the UK revealed a lack of skilled personnel in pharmaceutical companies. Around 93 employees from 59 pharmaceutical companies participated in the survey. More than 50% respondents in the survey expressed an urgent need to improve the availability of staff in 10 discipline areas. Owing to the shortage of skilled and knowledgeable professionals, companies tend to prefer conventional screening methods to cell-based assays; this presents a significant challenge to the growth of the HTS market

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Browse Related Reports:

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography – Global Forecast to 2024

In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

  Categories: